Expression of the ErbB-neuregulin signaling network during human cerebellar development: Implications for the biology of medulloblastoma

Cancer Research

Volumn 58, Issue 17, 1998, Pages 3932-3941

  Gilbertson, Richard J ^a,d   Clifford, Steven C ^b   MacMeekin, William ^c   Wright, Chris ^d   Perry, Robert H ^c   Kelly, Peter ^e   Pearson, Andrew D J ^d   Lunec, John ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b BIRMINGHAM WOMEN S HOSPITAL   (United Kingdom)

^c NEWCASTLE GENERAL HOSPITAL   (United Kingdom)

^d ROYAL VICTORIA INFIRMARY   (United Kingdom)

^e TEESSIDE UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

NEU DIFFERENTIATION FACTOR; TYROSINE KINASE RECEPTOR;

ARTICLE; BRAIN DEVELOPMENT; CEREBELLUM; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LOCALIZATION; FEMALE; GRANULE CELL; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MEDULLOBLASTOMA; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

BLOTTING, WESTERN; CEREBELLUM; GLYCOPROTEINS; HUMANS; IMMUNOHISTOCHEMISTRY; MEDULLOBLASTOMA; NEUREGULINS; POLYMERASE CHAIN REACTION; PROTO-ONCOGENE PROTEINS; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTOR, ERBB-2; RECEPTOR, ERBB-3;

EID: 0032170045     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (59)

1. Burden, S., and Yarden, Y. Neuregulins and their receptors: a versatile signalling module in organogenesis and oncogenesis. Neuron, 18: 847-855, 1997.
2. Hynes, N. E., and Stern, D. F. The biology of erbR-2/HER-2 and its role in cancer. Biochem. Biophys. Acta, 1198: 165-184, 1994.
3. r tumour antigen. Nature (Lond.), 312: 513-516, 1984.
4. Kraus, M. H., Issing, W., Toru, M., Popescu, N. C., and Aaronson, S. A. Isolation and characterisation of ERBB3, a third member of the ERBB/epidermal growth factor receptor family: evidence for overexpression in a subset of human mammary tumors. Proc. Natl. Acad. Sci. USA, 86: 9193-9197, 1989.
5. erbB4, a fourth member of the epidermal growth factor receptor family. Proc. Natl. Acad. Sci. USA, 90: 1746-1750, 1993.
6. Carraway, K. L., III, and Cantley, L. C. A Neu acquaintance for ErbB3 and ErbB4: a role for receptor heterodimerisation in growth signalling. Cell, 78: 5-8, 1994.
7. Alroy, I., and Yarden, Y. The ErbB signalling network in embryogenesis and oncogenesis: signal diversification through combinatorial ligand-receptor interactions. FEBS Lett., 410: 83-86, 1997.
8. Groenen, L. C., Nice, E. C., and Burgess, A. W. Structure function relationships for the EGF/TGF-α family of mitogens. Growth Factors, 11: 235-257, 1995.
9. Toyoda, H., Komursaki, T., Uchida, D., Takayama, Y., Isobe, T., Okuyama, T., and Hanada, K. Epiregulin. A novel epidermal growth factor with motigenic for rat primary hepatocytes. J. Biol. Chem., 270: 7495-7500, 1995.
10. Holmes, W. E., Sliwkowski, M. X., Akita, R. W., Henzl, W. J., Lee, J., Park, J. W., Yansura, D., Abadi, N., Raab, H., Lewis, G. D., Shepard, H. M., Kuang, W-J., Wood, W. I., Goeddel, D. V., and Vandlen, R. L. Identification of heregulin, a specific activator of p185erbB2. Science (Washington DC), 256: 1205-1210, 1992.
11. Marchionni, M. A., Goodearl, A. D. J., Chen, M. S., Bermingham-McDonogh, O., Kirk, C., Hendricks, M., Danehy, F., Misumi, D., Sudhalter, J., Kobayashi, K., Wroblewski, D., Lynch, C., Baldassare, M., Hiles, I., Davis, D. B., Hsuan, J. J., Totty, N. F., Otsu, M., McBurney, R. N., Waterfield, M. D., Stroobant, P., and Gwynne, D. Glial growth factors are alternatively spliced erbB2 ligands expressed in the nervous system. Nature (Lond.), 362: 312-318, 1993.
12. Chang, H., Riese, D. J., II, Gilbert, W., Stern, F. D., and McMahan, U. J. Ligands for the ErbB-family receptors encoded by a neuregulin like gene. Nature (Lond.), 387: 509-512, 1997.
13. Carraway, K. L., III, Weber, J. L., Unger, M. S., Ledesma, J., Yu, N., Gassman, M., and Lai, C. Neuregulin-2, a new ligand for ErbB3/ErbB4-receptor tyrosine kinases. Nature (Lond.), 387: 512-516, 1997.
14. Bushfield, S. J., Michnick, D. A., Chickering, T. W., Revett, T. L., Ma, J., Woolf, E. A., Comrack, C. A., Dussault, B. J., Woolf, J., Goodearl, A. D. J., and Gearing, D. P. Characterisation of a neuregulin-related gene, Don-1, that is highly expressed in restricted regions of the cerebellum and hippocampus. Mol. Cell. Biol., 17: 4007-4014, 1997.
15. Zhang, D., Sliwkowski, M. X., Mark, M., Frantz, G., Akita, R., Sun, Y., Hillan, K., Crowley, C., Brush, J., and Godowski, P. J. Neuregulin-3 (NRG3): a novel neural tissue enriched protein that binds and activates ErbB4. Proc. Natl. Acad. Sci. USA, 94: 9562-9567, 1997.
16. Ben-Baruch, N., and Yarden, Y. Neu differentiation factors. A family of alternatively spliced neuronal and mesenchymal factors. Proc. Soc. Exp. Biol. Med., 206: 221-227, 1994.
17. Schaefer, G., Fitzpatrick, V. D., and Sliwkowski, M. X. γ-Heregulin: a novel heregulin isoform that is an autocrine growth factor for the human breast cancer cell line, MDA-MB-175. Oncogene, 15: 1385-1394, 1997.
18. Barabacci, E. G., Guarino, B. C., Stroh, J. G., Singleton, D. H., Rosnack, K. J., Moyer, J. D., and Andrews, G. C. The structural basis for the specificity of epidermal growth factor and heregulin binding. J. Biol. Chem., 270: 9585-9589, 1995.
19. Summerfield, A., Hudnall, A. K., Lukas, T. J., Guyer, C. A., and Staros, J. Identification of residues of of the epidermal growth factor receptor proximal to residue 45 of bound epidermal growth factor. J. Biol. Chem., 271: 19656-19659, 1996.
20. Jacobsen, N. E., Abadi, N., Sliwkowski, M. X., Reilly, D., Skelton, N. J., and Fairbrother, W. J. High-resolution solution structure of the EGF-like domain of heregulin-α. Biochemistry, 35: 3402-3417, 1996.
21. Tzahar, E., Pinkas-Kramarski, R., Moyer, J. D., Klapper, L. N., Alroy, I., Levkowitz, G., Shelly, M., Henis, S., Eisenstein, M., Ratzkin, B. J., Sela, M., Andrews, G. C., and Yarden, Y. Bivalence of EGF-like ligands drives the ErbB signalling network. EMBO J., 16: 4938-4950, 1997.
22. Tzahar, E., Waterman, H., Chen, X., Levkowitz, G., Karunagaran, D., Lavi, S., Ratzkin, B. J., and Yarden, Y. A hierarchical network of interreceptor interactions determines signal transduction by neu differentiation factor/neuregulin and epidermal growth factor. Mol. Cell. Biol., 16: 5276-5287, 1996.
23. Graus-Porter, D., Beerli, R. R., Daly, J. M., and Hynes, N. E. ErbB-2, the preferred heterodimerization partner of all ErbB receptors, is a mediator of lateral signalling. EMBO J., 16: 1647-1655, 1997.
24. Karunagaran, D., Tzahar, E., Beerli, R. R., Chen, X., Graus-Porter, D., Ratzkin, B. J., Seger, R., Hynes, N. E., and Varden, Y. ErbB-2 is a common auxiliary subunit of NDF and EGF receptors: implications for breast cancer. EMBO J., 15: 254-264, 1996.
25. Carraway, K. L., III, and Burden, S. J. Neuregulins and their receptors. Curr. Opin. Neurobiol., 5: 606-612, 1995.
26. Lee, K-F., Simon, H., Chen, H., Bates, B., Hung, M-C., and Hauser, C. Requirement of neuregulin receptor erbB2 in neural and cardiac development. Nature (Lond.), 378: 394-398, 1995.
27. Riethmacher, D., Sonnberg-Riethmacher, E., Brinkmann, V., Yamaai, T., Lewin, G. R., and Birchmeier, C. Severe neuropathies in mice with targeted mutations in the ErbB3 receptor. Nature (Lond.), 389: 725-730, 1997.
28. Gassman, M., Casagranda, F., Orioli, D., Horst, S., Lai, C., Klein, R., and Lemke, G. Aberrant neural and cardiac development in mice lacking the ErbB4 neuregulin receptor. Nature (Lond.), 378: 390-394, 1995.
29. Meyer, D., and Birchmeier, C. Multiple essential functions of neuregulin in development. Nature (Lond.), 378: 386-390, 1995.
30. Carroll, S., Miller, M. L., Frohnert, P. W., Kim, S. S., and Corbett, J. A. Expression of neuregulins and their putative receptors, ErbB2 and ErbB3, is induced during Wallarian degeneration. J. Neurosci., 17: 1642-1659, 1997.
31. Seroogy, K. B., Gall, C. M., Lee, D. C., and Kornblum, H. I. Proliferative zones of postnatal rat brain express epidermal growth factor receptor mRNA. Brain Res., 670: 157-264, 1995.
32. Rio, C., Rieff, H. I., Qi, P., and Corfas, G. Neuregulin and erbB receptors play a critical role in neuronal migration. Neuron, 19: 39-50, 1997.
33. Ozaki, M., Sasner, M., Yano, R., Lu, H. S., and Buonanna, A. Neuregulin-β induces expression of an NMDA-receptor subunit. Nature (Lond.), 390: 691-694, 1997.
34. Pinkas-Kramarski, R., Eilam, R., Alroy, I., Levkowitz, G., lonai, P., and Yarden, Y. Differential expression of NDF/neuregulin receptors ErbB-3 and ErbB-4 and involvement in inhibition of neuronal differentiation. Oncogene, 15: 2803-2815, 1997.
35. O'Shea, S., Johnson, K., Moore, M., and Erikson, S. Heregulin, ErbB2, and ErbB3 heterozygous mice. Histological analysis and response to heregulin challenge. Proc. Am. Assoc. Cancer Res., 38: 554, 1997.
36. Pinkas-Kramarski, R., Eilam, R., Spiegler, O., Lavi, S., Liu, N., Chang, D., Wen, D., Schwartz, M., and Yarden, Y. Brain neurons and glial cells express Neu differentiation factor/heregulin: a survival factor for astrocytes. Proc. Natl. Acad. Sci. USA, 91: 9387-9391, 1994.
37. Kozmik, Z., Sure, U., Ruedi, D., Busslinger, M., and Aguzzi, A. Deregulated expression of PAX5 in medulloblastoma. Proc. Natl. Acad. Sci. USA, 92: 5709-5713, 1995.
38. Yokota, N., Aruga, J., Takai, S., Yamamda, K., Hamazaki, M., Iwase, T., Sugimura, H., and Mikoshiba, K. Predominant expression of human zic in cerebellar granule cell lineage and medulloblastoma. Cancer Res., 56: 377-383, 1996.
39. Gilbertson, R. J., Perry, R. H., Kelly, P. J., Pearson, A. D. J., and Lunec, J. Prognostic significance of HER2 and HER4 coexpression in childhood medulloblastoma. Cancer Res., 57: 3272-3280, 1997.
40. Gilbertson, R. J., Jaros, E., Perry, R. H., Kelly, P. J., Pearson, A. D. J., and Lunec, J. Mitotic percentage index: a new prognostic factor for childhood medulloblastoma. Eur. J. Cancer, 33: 609-615, 1997.
41. Chomczynski, P., and Sacchi, N. Single step method of RNA isolation by acid guanidinium thiocyanate phenol chloroform extraction. Anal. Biochem., 162: 156-159, 1987.
42. Clifford, S. C., Thomas, D. J., Neal, D. E., and Lunec, J. Increased mdr1 gene transcript levels in high grade carcinoma of the bladder determined by quantitative PCR-based assay. Br. J. Cancer, 69: 680-686, 1994.
43. Henniford, B. W., Shum-Siu, A., Leonberger, M. L., and Hendler, F. J. Variation in cellular EGF receptor mRNA expression demonstrated bt in situ reverse transcriptase polymerase chain reaction. Nucleic Acids Res., 21: 3159-3166, 1993.
44. Lowe, T., Shrefkin, J., Yang, S. Q., and Diffenbach, C. W. A computer program for selection of oligonucleotide primers for polymerase chain reactions. Nucleic Acids Res., 18: 1757-1761, 1990.
45. Tsai, C-M., Chang, K-T., Wu, L-H., Chen, J-Y., Gazdar, A. F., Mitsudomi, T., Chen, M-H., and Perng, R-P. Correlations between intrinsic chemoresistance and HER-2/neu gene expression, p53 gene mutations and cell proliferation characteristics in non-small cell lung cancer cell lines. Cancer Res., 56: 206-209, 1996.
46. Bitran, J. D., Samuels, B., Trujillo, Y., Klien, L., Schroeder, L., and Martinec, J. Her2/neu overexpression is associated with treatment failure in women with high-risk stage II and stage IIIA breast cancer (>10 involved lymph nodes) treated with high-dose chemotherapy and autologous haemopoeitic progenitor support following standard dose adjuvant chemotherapy. Clin. Cancer Res., 2: 1509-1513, 1996.
47. Yu, D., Wang, S-S., Dulski, K. M., Tsai, C-M., Nicholson, G. L., and Hung, M-C. c-erbB-2/neu overexpression enhances metastatic potential of human lung cancer cells by induction of metastasis-associated properties. Cancer Res., 54: 3260-3266, 1994.
48. Kern, J. A., Schwartz, D. A., Nordberg, J. E., Wiener, D. N., Greene, M. I., Torney, L., and Robinson, R. A. p185 overexpression in human lung adenocarcinomas predicts shortened survival. Cancer Res., 50: 5184-5191, 1990.
49. Di Fiore, P. P., Pierce, J., Kraus, M. H., Segatto, O., King, C. R., and Aaronson, S. A. c-erbB-2 is a potent oncogene when overexpressed in NIH/3T3 cells. Science (Washington DC), 237: 178-182, 1987.
50. HER2 causes transformation and tumorigenesis of NIH/3T3 cells. Proc. Natl. Acad. Sci. USA. 84: 7159-7163, 1987.
51. Kokai, Y., Myers, J. N., Wada, T., Brown, V. I., LeVea, C. M., Davis, J. G., Dobashi, K., and Greene, M. I. Synergistic interaction of p185c-neu and the EGF receptor leads to transformation of rodent fibroblasts. Cell, 58: 287-292, 1989.
52. Wallasch, C., Wiess, F. U., Niederfellner, G., Jallal, B., Issing, W., and Ullrich, A. Heregulin-dependent regulation of HER2/neu oncogenic signalling by heterodimerisation with HER3. EMBO J., 14: 4267-4275, 1993.
53. Zhang, K., Sun, J., Liu, N., Chang, D., Thomason, A., and Yoshinaga, S. K. transformation of NIH 3T3 cells by HER3 or HER4 receptors requires the presence of HER1 or HER2. J. Biol. Chem., 271: 3884-3890, 1996.
54. Altman, J. Morphological development of the rat cerebellum and some of its mechanisms. Exp. Brain Res. Suppl., 6: 8-49, 1982.
55. Elenius, K., Corfas, G., Paul, S., Choi, C. J., Rio, C., Plowman, G., and Klagsbrun, M. A novel juxtamembrane domain isoform of HER4/ErbB4. Isoform-specific tissue distribution and differential processing in response to phorbol ester. J. Biol. Chem., 272: 26761-26768, 1997.
56. Press, M. F., Cordon-Cardo, C., and Slamon, D. J. Expression of the HER2/neu proto-oncogene in normal adult and fetal tissues. Oncogene, 5: 953-962, 1990.
57. Johnson, G. R., Saeki, T., Gordon, A. W., Shoyab, M., Saloman, D. S., and Stromberg, K. Autocrine action of amphiregulin in a colon carcinoma cell line and immunohistochemical localisation of amphiregulin in human colon. J. Cell Biol., 118: 741-751, 1992.
58. Li, W., Park, J. W., Nuijens, A., Sliwkowski, M. X., and Keller, G. A. Heregulin is rapidly translocated to the nucleus and its transport is correlated with c-myc induction in breast cancer cells. Oncogene, 12: 2473-2477, 1996.
59. Batra, S. K., Rasheed, B. K. A., Bigner, S. H., and Bigner, D. D. Biology of disease: oncogenes and antioncogenes in human central nervous system tumours. Lab. Invest., 71: 621-637, 1995.